GENEREX BIOTECHNOLOGY CORP Business Finance Contracts & Agreements
144 Contracts & Agreements
- Debenture Agreements (6 contracts)
- Guaranty Agreements (1)
- Investor Rights Agreements (1)
- Note Agreements (10)
- Purchase Agreements (17)
- Registration Rights Agreements (16)
- Release Agreements (1)
- Security Agreements (3)
- Shareholders Agreements (1)
- Stock Agreements (35)
- Waiver Agreements (3)
- Warrant Agreements (50)
- CONVERTIBLEPROMISSORY NOTE (Filed With SEC on September 3, 2020)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on September 3, 2020)
- Securities Purchase Agreement dated as of August 4, 2020 between the Company and each buyer a signatory thereto (Filed With SEC on August 7, 2020)
- Registration Rights Agreement dated as of August 4, 2020 between the Company and each other party a signatory thereto (Filed With SEC on August 7, 2020)
- Form of Series D Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)
- Form of Series C Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)
- THEISSUE PRICE OF THIS NOTE IS $100,000.00 (Filed With SEC on June 22, 2020)
- THEISSUE PRICE OF THIS NOTE IS $50,000.00 (Filed With SEC on June 22, 2020)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 18, 2020)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 18, 2020)
- STOCK PURCHASE AGREEMENT CONFIDENTIAL DRAFT: for discussion Purposes ONLY (Filed With SEC on November 27, 2019)
- COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 22, 2019)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 22, 2019)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 22, 2019)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 15, 2019)
- COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 15, 2019)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 15, 2019)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2019)
- AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 11, 2019)
- PLEDGE AND SECURITY AGREEMENT CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)
- PROMISSORY NOTE (Filed With SEC on January 11, 2019)
- STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)
- AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (Filed With SEC on January 11, 2019)
- PLEDGE AND SECURITY AGREEMENT (Filed With SEC on January 11, 2019)
- PROMISSORY NOTE CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)
- STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)
- STOCK PLEDGE AGREEMENT (Filed With SEC on December 3, 2018)
- NOTE DUENovember 26, 2019 (Filed With SEC on December 3, 2018)
- AGREEMENT,ASSIGNMENT AND RELEASE (Filed With SEC on December 3, 2018)
- Formof Warrant To Purchase Common Stock (Filed With SEC on December 3, 2018)
- NOTE DUEOCTOBER 26, 2019 (Filed With SEC on October 26, 2018)
- CONFIDENTIALAMENDMENT TO SECURITIES PURCHASE AGREEMENT THISAMENDMENT (this “Amendment”) is made as of this day of June, 2018 by and between: GENEREXBIOTECHNOLOGY CORPORATION... (Filed With SEC on July 9, 2018)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 29, 2017)
- GENEREXBIOTECHNOLOGY CORPORATION NOTICETO WARRANT HOLDERS February__, 2017 (Filed With SEC on February 15, 2017)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on June 25, 2015)
- COMMONSTOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on June 25, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 28, 2014)
- COMMON STOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on March 28, 2014)
